Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

Abstract Background Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic i...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2021-05-01
Schriftenreihe:	Thoracic Cancer
Schlagworte:	adjuvant chemotherapy biomarker galectin‐3 immunohistochemistry non‐small cell lung cancer
Online-Zugang:	https://doi.org/10.1111/1759-7714.13945
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!